Prime Healthcare Services - Saint John Leavenworth, LLC

Prime Healthcare Services - Saint John Leavenworth, LLC was paid $857K by Medicaid between Jan 2018 and Nov 2024, across 49 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.

33Billing provider infoPRIME HEALTHCARE SERVICES - SAINT JOHN LEAVENWORTH, LLC
LEAVENWORTH, KS 66048

33aNPI1568705267assigned 04/01/2013

33bProvider typeGeneral Acute Care Hospital

28Total paid$857K

24GClaims40,499

24DCodes billed49

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other General Acute Care Hospital providers in Kansas

Rank by total paid#21 of 48

Median peer was paid$461K

This provider vs. median1.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	4,304	$124K
2019	3,230	$74K
2020	3,463	$57K
2021	5,757	$112K
2022	8,938	$188K
2023	10,020	$190K
2024incomplete	4,787	$111K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	33%	6,166	5,674	$283K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	23%	4,192	3,855	$198K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	16%	3,035	2,660	$138K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	4.8%	722	652	$41K
80053	Comprehensive metabolic panel	3.2%	3,009	2,624	$27K
87428		3.0%	779	697	$25K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.6%	4,661	4,082	$23K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.9%	783	692	$16K
96361	Intravenous infusion, hydration; each additional hour	1.4%	686	590	$12K
81001		1.3%	2,966	2,679	$11K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.3%	1,005	790	$11K
96375	Therapeutic injection; each additional sequential IV push	1.1%	339	296	$9K

37 more codes

87804	Infectious agent antigen detection by immunoassay; Influenza, each type	1.1%	553	$9K
71045	Radiologic examination, chest; single view	<1%	658	$9K
80048	Basic metabolic panel (calcium, ionized)	<1%	662	$8K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	133	$6K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	245	$4K
84484		<1%	477	$4K
81025		<1%	430	$4K
80076		<1%	311	$3K
36415	Collection of venous blood by venipuncture	<1%	5,677	$2K
83690		<1%	342	$2K
70450	Computed tomography, head or brain; without contrast material	<1%	12	$1K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	133	$1K
71046	Radiologic examination, chest; 2 views	<1%	63	$1K
87070		<1%	121	$1K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	83	$905.33
83735		<1%	132	$849.75
85610		<1%	156	$688.55
82550		<1%	94	$612.76
85730		<1%	123	$578.30
87086	Culture, bacterial; quantitative colony count, urine	<1%	50	$525.62
83880		<1%	33	$513.72
84443	Thyroid stimulating hormone (TSH)	<1%	35	$462.55
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	31	$420.64
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	14	$311.45
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	18	$252.66
87420		<1%	14	$153.21
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	133	$121.19
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	161	$120.15
85027		<1%	23	$94.64
83605		<1%	18	$85.31
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	51	$62.60
85007		<1%	37	$23.29
81003		<1%	14	$17.61
J7030	Infusion, normal saline solution , 1000 cc	<1%	925	$12.72
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	102	$4.42
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	16	$0.26
J7120	Ringers lactate infusion, up to 1000 cc	0%	76	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEON, LUIS (PRESIDENT OF OPERATIONS II)